Afucosylated IgG defines an exacerbated phenotype in COVID-19: afucosylated immune complexes in the lungs trigger an inflammatory infiltrate and cytokine production dependent on the expression of the receptor for afucosylated IgGs, FcγRIIIa (CD16a) in monocytes [43]. This evidence concerns the gene FCGR3A and COVID-19.